Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 778 results
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
Matthews KA, Senagbe KM, Nötzel C, Gonzales CA, Tong X, Rijo-Ferreira F, Bhanu NV, Miguel-Blanco C, Lafuente-Monasterio MJose, Garcia BA et al..  2020.  Disruption of the Plasmodium falciparum Life Cycle through Transcriptional Reprogramming by Inhibitors of Jumonji Demethylases.. ACS Infect Dis. 6(5):1058-1075.
Matteoli G, Mazzini E, Iliev ID, Mileti E, Fallarino F, Puccetti P, Chieppa M, Rescigno M.  2010.  Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction.. Gut. 59(5):595-604.
Mastrangeli A, Harvey BG, Yao J, Wolff G, Kovesdi I, Crystal RG, Falck-Pedersen E.  1996.  "Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype.. Hum Gene Ther. 7(1):79-87.
Martin A, Schneider S, Schwer B.  2002.  Prp43 is an essential RNA-dependent ATPase required for release of lariat-intron from the spliceosome.. J Biol Chem. 277(20):17743-50.
Marrero J, Rhee KY, Schnappinger D, Pethe K, Ehrt S.  2010.  Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infection.. Proc Natl Acad Sci U S A. 107(21):9819-24.
Marrero J, Trujillo C, Rhee KY, Ehrt S.  2013.  Glucose phosphorylation is required for Mycobacterium tuberculosis persistence in mice.. PLoS Pathog. 9(1):e1003116.
Mao N, Zhou Q, Kojic M, Pérez-Martín J, Holloman WK.  2007.  Ortholog of BRCA2-interacting protein BCCIP controls morphogenetic responses during DNA replication stress in Ustilago maydis.. DNA Repair (Amst). 6(11):1651-60.
Mao N, Kojic M, Holloman WK.  2009.  Role of Blm and collaborating factors in recombination and survival following replication stress in Ustilago maydis.. DNA Repair (Amst). 8(6):752-9.
malERA Consultative Group on Basic Science and Enabling Technologies.  2011.  A research agenda for malaria eradication: basic science and enabling technologies.. PLoS Med. 8(1):e1000399.
R Malcolm K, Veazey RS, Geer L, Lowry D, Fetherston SM, Murphy DJ, Boyd P, Major I, Shattock RJ, Klasse PJohan et al..  2012.  Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaques.. Antimicrob Agents Chemother. 56(5):2251-8.
Maksymiuk C, Balakrishnan A, Bryk R, Rhee KY, Nathan C.  2015.  E1 of α-ketoglutarate dehydrogenase defends Mycobacterium tuberculosis against glutamate anaplerosis and nitroxidative stress.. Proc Natl Acad Sci U S A. 112(43):E5834-43.
MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan C.  1997.  Identification of nitric oxide synthase as a protective locus against tuberculosis.. Proc Natl Acad Sci U S A. 94(10):5243-8.
MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N.  1995.  Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase.. Cell. 81(4):641-50.
Mackley EC, Houston S, Marriott CL, Halford EE, Lucas B, Cerovic V, Filbey KJ, Maizels RM, Hepworth MR, Sonnenberg GF et al..  2015.  CCR7-dependent trafficking of RORγ⁺ ILCs creates a unique microenvironment within mucosal draining lymph nodes.. Nat Commun. 6:5862.
Mack CA, Song WR, Carpenter H, Wickham TJ, Kovesdi I, Harvey BG, Magovern CJ, Isom OW, Rosengart T, Falck-Pedersen E et al..  1997.  Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.. Hum Gene Ther. 8(1):99-109.
Ma X, Sun J, Papasavvas E, Riemann H, Robertson S, Marshall J, Bailer RT, Moore A, Donnelly RP, Trinchieri G et al..  2000.  Inhibition of IL-12 production in human monocyte-derived macrophages by TNF.. J Immunol. 164(4):1722-9.
Ma X, D'Andrea A, Kubin M, Aste-Amezaga M, Sartori A, Monteiro J, Showe L, Wysocka M, Trinchieri G.  1995.  Production of interleukin-12.. Res Immunol. 146(7-8):432-8.
Ma X.  2001.  TNF-alpha and IL-12: a balancing act in macrophage functioning.. Microbes Infect. 3(2):121-9.
Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G.  1996.  The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells.. J Exp Med. 183(1):147-57.
Ma X, Saitoh N, Curtis PJ.  1993.  Purification and characterization of a nuclear DNA-binding factor complex containing topoisomerase II and chromosome scaffold protein 2.. J Biol Chem. 268(9):6182-8.
Ma X, Riemann H, Gri G, Trinchieri G.  1998.  Positive and negative regulation of interleukin-12 gene expression.. Eur Cytokine Netw. 9(3 Suppl):54-64.
Ma X, Aste-Amezaga M, Gri G, Gerosa F, Trinchieri G.  1997.  Immunomodulatory functions and molecular regulation of IL-12.. Chem Immunol. 68:1-22.
Ma X, Neurath M, Gri G, Trinchieri G.  1997.  Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter.. J Biol Chem. 272(16):10389-95.
Ma X, Montaner LJ.  2000.  Proinflammatory response and IL-12 expression in HIV-1 infection.. J Leukoc Biol. 68(3):383-90.
Ma X, Gri G, Trinchieri G.  1996.  A novel ets-2-related nuclear factor is involved in transcriptional activation of the human interleukin-12 p40 gene promoter in response to interferon-gamma and LPS stimulation of monocytic cells.. Ann N Y Acad Sci. 795:357-60.